Salivary Proteomics Reveals Protein Changes During Multiple Sclerosis Treatment
-
November 16, 2026
-
2 min
November 16, 2026
A little heartbreak, a dash of matcha, strange dreams, and one very hairy experiment are on the docket this week.
by Teraya Smith
November 12, 2026
In a 12,327-patient trial, asundexian cut recurrent ischemic stroke risk by 26% alongside antiplatelets.
by Mouj Hijazi
November 10, 2026
Board-certified neurosurgeon Jonathan Miller, M.D., has joined Marcus Neuroscience Institute, a part of Baptist Health.